SCHEMBL2214072

SCHEMBL2214072

CC(=O)Nc1cccc(-c2cccc(-c3cc4ccnn4c(S(C)(=O)=O)n3)c2)c1.COc1cccc(-c2cccc(-c3cc4ccnn4c(S(C)(=O)=O)n3)c2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FYN P06241 4/20 0.50
ADORA1 P30542 3/20 0.49
ADORA3 P0DMS8 2/20 0.49
ADORA2B P29275 2/20 0.49
BRAF P15056 5/20 0.48
ADORA2A P29274 2/20 0.47
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 1/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
PIK3CA P42336 1/20 0.43
CYP3A4 P08684 1/20 0.42
RAD52 P43351 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2882567 0.93 RAD52 (0.47) FYNBRAFALDH1A1SMN1; SMN2NPC1
SCHEMBL2882272 0.88 FYN (0.48) FYNALDH1A1HPGDSMN1; SMN2NPC1
SCHEMBL2319146 0.85 FYN (0.51) FYNADORA1ADORA3ADORA2BBRAF
SCHEMBL2214323 0.84 ALDH1A1 (0.41) ADORA1ADORA3ADORA2BALDH1A1HPGD
SCHEMBL2211969 0.84 FYN (0.44) FYNALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL2209412 0.82 ABL1 (0.41) ALDH1A1HPGDSMN1; SMN2HTTRAB9A
SCHEMBL2209540 0.77 BPTF (0.36) ALDH1A1HPGDSMN1; SMN2HTTRAB9A
SCHEMBL2880093 0.76 RAD52 (0.48) FYNBRAFALDH1A1SMN1; SMN2NPC1
SCHEMBL2881702 0.74 KDM4E (0.45) ADORA3ALDH1A1HPGDSMN1; SMN2NPC1
SCHEMBL2213858 0.72 CDK2 (0.42) ALDH1A1HPGDSMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1797096-B1 PYRAZOLOPYRIMIDINES AS INHIBITORS OF PROTEIN KINASE B (AKT) BAYER SCHERING PHARMA AG (DE) 2011-07-27 EP disclosed